Lava Therapeutics NVLVTX
13F holders, Q3 2025 (September 30)21holders +2
8new positions
6sold out
1famous investor
$1.56avg. 13F price*
At the end of Q3 2025, 21 institutions reported holding Lava Therapeutics NV (LVTX) in their 13F filings, up 2 from Q2 2025. 8 opened new positions and 6 sold out. The largest holders were Shay Capital LLC ($4.0M), Redmile Group, LLC ($3.2M) and BML Capital Management, LLC ($3.1M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lava Therapeutics NV
- CUSIP
- N51517105
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $4.5M |
| Exits | 6 | $966K |
All 13F filers, Q2 2025 → Q3 2025: 3,005,673 shares bought and 732,031 shares sold, net +2,273,642 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Shay Capital LLC | 0.72% | New | 2,548,730 | $4.0M |
| Redmile Group, LLC | 0.31% | No change | 2,074,372 | $3.2M |
| BML Capital Management, LLC | 2.83% | No change | 1,970,610 | $3.1M |
| Sanofi | 1.15% | No change | 1,919,455 | $3.0M |
| Merck & Co., Inc. | 0.79% | No change | 1,149,345 | $1.8M |
| GTS Securities LLC | 0.01% | New | 200,000 | $312K |
| Rangeley Capital, LLC | 0.25% | Add +509.5% | 165,000 | $257K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 65,000 | $101K |
| Citadel Advisors | 0.00% | Add +2.9% | 53,308 | $83K |
| Royal Bank of Canada | 0.00% | New | 44,348 | $69K |
| Lepercq De Neuflize Asset Management LLC | 0.03% | No change | 31,000 | $48K |
| JBF Capital, Inc. | 0.01% | New | 23,911 | $37K |
| XTX Topco Ltd | 0.00% | New | 21,727 | $34K |
| UBS Group AG | 0.00% | Reduce -3.1% | 15,871 | $25K |
| Torno Capital, LLC | 0.00% | New | 15,000 | $23K |
| Geode Capital Management, LLC | 0.00% | No change | 14,170 | $22K |
| Equitec Proprietary Markets, LLC | 0.12% | New | 12,500 | $20K |
| Tsfg, LLC | 0.00% | No change | 400 | $1K |
| Jones Financial Companies LLLP | 0.00% | No change | 400 | $636 |
| SBI Securities Co., Ltd. | 0.00% | No change | 300 | $468 |
| Smallwood Wealth Investment Management, LLC | 0.00% | New | 26 | $40 |
"% of holder's portfolio" is LVTX's weight in each manager's 13F, not the share of Lava Therapeutics NV the manager owns.